• 00:45

    Clinical Air Episode #11: How can Digital Complement and Disrupt Clinical Trials

    in Science

    Donald Jones, Chief Digital Officer, Scripps Translational Science Institute talks with host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer on what's happening with digital in drug development. Don discusses his thoughts on the evolution of new products with digital and the “digitazation” of tools for clinical trials. He also shares his thoughts on the biggest disruptors in pharma. 


    Don and Craig will be featured in an interview as well at DPharm: Disruptive Innovations to Advance Clinical Trials on September 11, 2014 in Boston.


    Host
    Craig Lipset
    Head of Clinical Innovation, R&D
    Pfizer


    Guest
    Donald Jones
    Chief Digital Officer
    Scripps Translational Science Institute
    &
    Founder & Chairman, Wireless Life Sciences Alliance


    Producer
    Valerie Bowling
    Executive Director
    The Conference Forum


     


     

  • 00:37

    Clinical Air Episode # 10 Patients as Partners in Clinical Trials

    in Science

    Join host, Craig H. Lipset, Head of Clinical Innovation, R&D, Pfizer lead a discussion on what it really means to partner with patients in clinical trials.


    Guests include:


    Jeri Burtchell, Founder, Partners in Research


    Regina Holliday, Artist and Medical Advocate


    For more information on Jeri's new launch, visit: Healthivibe.com and for Regina walking gallary, google Regina Holliday, walking gallary.


    For more information on the topic of Patients as Partners, visit www.theconferenceforum.org. The Conference Forum presented a program in March 2014 fully dedicated to understanding the journey a patient takes in clinical trials. Also take a look at Disruptive Innovations to Advance Clinical Trials scheduled for September 11-12, 2014 in Boston. This event addresses significant innovation to help improve a patients experience in a clinical trial.


     

  • 01:05

    Clinical Trials in Prostate Cancer with Dr. Ian Thompson, UTHSC

    in Health

     Dr. Ian Thompson is Professor, Glenda and Gary Woods Distinguished Chair in GU Oncology at The University of Texas Health Science Center, San Antonio. Dr. Ian Thompson received his undergraduate degree from West Point and his M.D. degree from Tulane University. After a Residency in Urology in San Antonio, he completed a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center. Dr. Thompson has published over 400 scientific papers, several dozen book chapters, and has edited five textbooks in medicine and surgery. He currently serves as Vice-Chair of the Early Detection Research Network of the National Cancer Institute and is Chair of the Genitourinary Committee of the Southwest Oncology Group, the largest clinical trials organization supported by the National Cancer Institute. Dr. Thompson is the Principal Investigator of the San Antonio Center for Biomarkers Of Risk of Prostate Cancer. This cohort study, with up to 8 years of followup, currently follows over 3,600 men for development of prostate cancer and has been the source of many recent important developments in the early detection of prostate cancer.


    Our prostate cancer panels are conducted in association with Prostate Cancer International and Prostate Cancer Foundation. 


    RSVP here (or) mail priya@trialx.com


     

  • 01:04

    Exploring the Myths and Benefits of Clinical Trials

    in Family

    Our guest on Monday, February 10, 2014 is David Fuehrer. Dave is a two-time testicular cancer survivor and President of CureLauncher, a company he cofounded. Prior to doing so, Dave spent 10 years developing new products across North America, China and Europe for Pfizer, General Electric, Dow and many others.


    Dave will share his mission to solve the clinical trial enrollment problem that currently exists in the United States.  His company and website connects people to lifesaving medical treatments that they might otherwise be unaware exist. Some of the best medical treatment can be found in clinical trials, but few know or trust them enough to seek them out.


    Join us as we discuss the myths and invaluable services CureLauncher and clinical trials provides to patients and the medical community.

  • 00:30

    Finding Hope

    in Health

    Mike and Joyce speak with Dana Dornsife, President and Founder of an organization called Lazarex that helps people identify and participate in clinical trials that may be appropriate for their condition.


    Dana first became involved in cancer patient advocacy when her brother-in-law, Mike Miller, was diagnosed with pancreatic cancer in 2003. Mike had three children, the youngest of whom was only four years old.


    Dana and her family searched for options for Mike that would buy the family some time and found a clinical trial treatment. Mike was treated successfully and lived long enough for his youngest daughter to have real memories of him.


    Since then, Dana has fought tirelessly for improved options for cancer patients who have been told there is no hope left.


    Lazarex Cancer Foundation was formed in 2006 to build a bridge to hope, dignity and life for cancer patients and their families. It provides financial assistance to defray the costs associated with patient participation in FDA clinical trials. Additionally, it helps patients navigate their clinical trial options and provide community education and outreach services.


        - helps patients of all ages and walks of life, with all forms of cancer.
        - helps patients take advantage of medical breakthroughs today, because they may not have a tomorrow.
        - believes that the size of a patient's checkbook should not stand between them and the choices they make or the treatments they need.
        - provides resources to fill the gap that exists between when a patient is told there is no more hope and when they are truly done with their journey in life.


    For more information, see <a href="http://www.lazarex.org">http://www.lazarex.org</a>

  • 00:59

    MTHFR, B Vits, EMR, Clinical Decisions, Grief

    in Health

    Discussion of MTHFR, use of methyl B vitamins, EMR rants from my blog, Clinical Decision Making, a few more incidentaloma comments and Grief in December from another of my blog posts.  Dr Synonymous (Pat Jonas, MD) reviews blogs, tweets and the medical literature.  He is a Board-Certified Family Physician who is holistic minded and curious about the human condition.


    Listen in as he reflects on the health care system, Family Medicine and holistic health.

  • 00:31

    Testimony of Trials And Endurance: The Plane Truth

    in Christianity

    Elaine and Dave Costanzo,radio talk show hosts and ministry leaders of New England Christian Coffeehouses, and owners of ABS Technologies join host Kathryn MacDonald for an incredible testimony about Elaine survivIng major brain and back surgeries after a terrible accident. How did Dave and Elaine endure these overwhelming trials? Tune in tonight @ 6:30pm on THE GOD REPORT

  • 00:15

    "Fiery Trials"

    in Christianity

    Greetings and Salutations beloved brethren! Today I will share with the listening audience a message that I received from the Lord pertaining to the "fiery trials" that we who are servants of our Lord Jesus will have to endure as we walk the narrow path of salvation. I want to encourage each and everyone of you my brethren to look up for your redemption draws near. Our Lord will be coming in the clouds, to redeem this fallen world from the enemy of our souls. Also, I will present a text of scripture from Romans 1:18-32 which talks about the sin that so easilly besets us. It is high time my brethren that we repent of our sin, and live lives that glorify our most holy Lord. God Bless!


    Prepare your hearts my brethren for it is time that we who are of the household of faith rise up in the power and might of the Holy Ghost and preach the gospel to every creature, as our Lord has commissioned us to do!

  • 00:31

    Going outside your comfort zone for medical care

    in Health

    Mike and Joyce chat about the adventure of going outside your comfort zone for medical care.


    Joyce has been hosting a family from a village on the west coast of Ecuador who are in Boston to get life-saving heart surgery for their son.  Not only have they traveled a great distance, but Boston has very different weather than the tropical weather of Ecuador, the food is entirely different, and they don't speak any English.


    They also chat about some of the highlights of the shows of 2014, and foreshadow next week's Christmas week show about considering clinical trials, and the resources that are available to assist you in finding and joining clinical trials that might be helpful in your situation.


    Many thanks for listening in 2014, we hope you enjoy next week's show, and that you will be with us in 2015, happy and in good health.


    Be well, and be a Powerful Patient.


     

  • 00:33

    Faith in trials

    in Christianity

    As far as I can remember, I’ve never enjoyed trials. Trials are difficult, troublesome often confusing times, and quite frankly, are not nice.

    Without trials, we would not be hoping for a better time, because we wouldn’t need it; we wouldn’t see the need to depend on God; we wouldn’t grow as Christians, and we wouldn’t have love and compassion for others.

  • 00:48

    Risk Based Monitoring: New Thinking on Clinical Oversight

    in Science

    Since the FDA and EMA published their current thinking on clinical oversight and risk-based monitoring (RBM) strategies, the topic has received a magnitude of attention, commanding column inches, webinar discussions and industry conferences. With so much discussion going on, it is unsurprising that many sponsors are feeling out in the cold when it comes to identifying how to practically implement RBM strategies within study designs. As data quality matters most in determining study success and ensuring patient safety, the latest recommendations have created growing demand for solutions that simplify the transition to risk-based techniques.


    In this program, our guests discuss how emerging technologies and Central Statistical Monitoring (CSM) now present more practical means of implementing successful RBM strategies. Both Sanofi and Novartis will provide a large pharma perspective on making the move to RBM.


    Host: Valerie Bowling, Executive Director, The Conference Forum


    Guests:


    Marc Buyse, Founder, International Drug Development Institute & CluePoints


    Eric Genevois-Marlin, VP, Biostatistics & Programming, Sanofi


    Thomas Haag, Data Integrity Process Expert, eClinical Quality Assurance, Novartis Pharmaceuticals


     


     

Results Per Page: 12 | 24 | 48
Loading...
Loading...